Zobrazeno 1 - 10
of 334
pro vyhledávání: '"Taro, Toyoda"'
Autor:
Midori Yamasaki, Toshiyuki Maki, Taisuke Mochida, Teruki Hamada, Saori Watanabe-Matsumoto, Shuhei Konagaya, Manami Kaneko, Ryo Ito, Hikaru Ueno, Taro Toyoda
Publikováno v:
Cell Transplantation, Vol 33 (2024)
In the development of cell therapy products, immunocompromised animal models closer in size to humans are valuable for enhancing the translatability of in vivo findings to clinical trials. In the present study, we generated immunocompromised type 1 d
Externí odkaz:
https://doaj.org/article/930002bc43534fc4ae15819b48168a79
Autor:
Ryo Ito, Azuma Kimura, Yurie Hirose, Yu Hatano, Atsushi Mima, Shin-Ichi Mae, Yamato Keidai, Toshihiro Nakamura, Junji Fujikura, Yohei Nishi, Akira Ohta, Taro Toyoda, Nobuya Inagaki, Kenji Osafune
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract For pluripotent stem cell (PSC)-based regenerative therapy against diabetes, the differentiation efficiency to pancreatic lineage cells needs to be improved based on the mechanistic understanding of pancreatic differentiation. Here, we aimed
Externí odkaz:
https://doaj.org/article/df2cb19d80214e9ca8bdf82af4846cfd
Autor:
Kensuke Sakuma, Noriko Tsubooka-Yamazoe, Kiyohiro Hashimoto, Nozomu Sakai, Shinya Asano, Saori Watanabe-Matsumoto, Takeshi Watanabe, Bunnai Saito, Hirokazu Matsumoto, Hikaru Ueno, Ryo Ito, Taro Toyoda
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Background Transplantation of differentiated cells from human-induced pluripotent stem cells (hiPSCs) holds great promise for clinical treatments. Eliminating the risk factor of malignant cell transformation is essential for ensuring the saf
Externí odkaz:
https://doaj.org/article/a21dd5df379540a8874afc1118b6fef0
Autor:
Hideyuki Hiyoshi, Kensuke Sakuma, Noriko Tsubooka-Yamazoe, Shinya Asano, Taisuke Mochida, Junji Yamaura, Shuhei Konagaya, Ryo Fujii, Hirokazu Matsumoto, Ryo Ito, Taro Toyoda
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract The differentiation of pancreatic endocrine cells from human pluripotent stem cells has been thoroughly investigated for their application in cell therapy against diabetes. Although non-endocrine cells are inevitable contaminating by-product
Externí odkaz:
https://doaj.org/article/230766f713d141caa8dc083eae065981
Autor:
Ryo Suenaga, Shuhei Konagaya, Junji Yamaura, Ryo Ito, Satoshi Tanaka, Yoichi Ishizaki, Taro Toyoda
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Pluripotent stem-cell derived cells can be used for type I diabetes treatment, but we require at least 105–106 islet-like clusters per patient. Although thousands of uniform cell clusters can be produced using a conventional microwell plat
Externí odkaz:
https://doaj.org/article/f8192a40b43144d49be1ffed9ba38ecb
Autor:
Hideyuki Hiyoshi, Kensuke Sakuma, Shinya Asano, Napier, Stephanie C., Shuhei Konagaya, Taisuke Mochida, Hikaru Ueno, Takeshi Watanabe, Yoshiaki Kassai, Hirokazu Matsumoto, Ryo Ito, Taro Toyoda
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 4/16/2024, Vol. 121 Issue 16, p1-11, 38p
Publikováno v:
ACS Photonics. 10:265-273
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a90e2582f63119495458b532e42effc
https://doi.org/10.1021/acsphotonics.2c01609
https://doi.org/10.1021/acsphotonics.2c01609
Publikováno v:
Materials Research Express, Vol 9, Iss 4, p 049501 (2022)
Externí odkaz:
https://doaj.org/article/b03f844ebbde4e85822dd0a88d6e85fb
Publikováno v:
Materials Research Express, Vol 9, Iss 2, p 025005 (2022)
The photovoltaic properties of quantum dot (QD) sensitized solar cells (QDSCs) depend significantly on the surface modification applied to the QDs and on the nanostructured interface between the QDs and the electrode surface. In the development of QD
Externí odkaz:
https://doaj.org/article/67500052d40648bcb90a06c0ca461fda
Publikováno v:
Stem Cell Research, Vol 24, Iss C, Pp 61-68 (2017)
While pancreatic islet transplantation achieves insulin independence in type 1 diabetes (T1D) patients, its widespread application is limited by donor tissue scarcity. Pancreatic progenitor cells (PPCs) give rise to all cell types in the pancreas dur
Externí odkaz:
https://doaj.org/article/a43bb141675744d4b06a3b0ac06b8ef1